Anton Rx Report

Ok….. here’s something innovative in the wacky world of specialty pharmacy! CVS has launched a new subsidiary called Cordavis. The new entity “will work directly with

The article below was published some weeks ago, but its insight is very timely. It is a simple story….. one in which the Pharma industry is

Catching up on recent FDA approvals. The FDA recently approved a new oral therapy, Sohonos (palovarotene) from Ipsen Biopharmaceuticals, for reduction in the volume of

Catching up on recent approvals…….. The FDA recently approved a new oral therapy, Akeega (niraparib and abiraterone acetate) from Janssen Pharmaceutical, the first-and-only dual action

Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely

It’s ALIVE!!!  Artificial Intelligence is here. The article below details how HCSC, which covers about 18 million members in Illinois, Montana, New Mexico, Oklahoma and Texas,

Catching up on a slew of FDA approvals in recent weeks….. whew! The FDA  recently approved a new therapy, Veopoz (pozelimab-bbfg) from Regeneron, for the treatment

Catching up on recent approvals….. Earlier this week we sent a Report on the approval of Talvey from Janssen Pharmaceuticals indicated for he treatment of

Catching up on recent approvals….. The FDA recently approved a new subcutaneous therapy, Talvey (talquetamab-tgvs) from Janssen Pharmaceutical (a J&J company) for the treatment of

Now here’s a two-fer for ya. First, there’s the news that another specialty pharmacy has been christened. Second, we learn what a group of zebras